You are currently viewing a new version of our website. To view the old version click .

Drugs and Drug Candidates, Volume 2, Issue 4

December 2023 - 8 articles

Cover Story: Multiple agonists of the kappa opioid receptor (KOR) have recently been approved as safe and effective therapeutic agents for itching conditions (pruritis). Exciting recent findings by several different investigative teams have demonstrated consistent robust effectiveness in animal models of demyelinating disorders, including experimental autoimmune encephelomyelitis. The precise mechanisms underlying the effectiveness of KOR agonists in ameliorating the clinical effects in animal demyelination models require further investigation, but KOR-induced remyelination has been shown to be involved in several of the studies. This summary of the published work on KOR agonists in demyelination disorder models presents the diverse structural classes of KOR agonists investigated, with comparisons of effects, and discussion of potential future directions. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Review
  • Open Access
2 Citations
5,397 Views
14 Pages

The Effects of Vitamin D on Preventing Hyperglycemia and a Novel Approach to Its Treatment

  • Suchitra Monapati,
  • Pavani Kaki,
  • Mary Stella Gurajapu,
  • Prathibha Guttal Subhas and
  • Harinadha Baba Kudipudi

28 November 2023

The dietary reference levels for vitamin D were established with an emphasis on its role in bone health; however, with the identification of vitamin D receptors in all body tissues novel associations with other metabolic disorders, such as diabetes,...

  • Review
  • Open Access
17 Citations
4,207 Views
25 Pages

22 November 2023

This review article emphasizes the current enlargements in the formation and properties of the various nanostructured aggregates resulting from the self-assembly of a variety of block copolymers (BCPs) in an aqueous solution. The development of the d...

  • Review
  • Open Access
1 Citations
3,126 Views
15 Pages

10 November 2023

Multiple sclerosis (MS) afflicts millions of people worldwide. While multiple therapeutics have recently been developed and approved as treatment agents, they are not 100% effective. Recent developments investigating the endogenous opioid system invo...

  • Feature Paper
  • Review
  • Open Access
5,293 Views
18 Pages

24 October 2023

For decades, oxybutynin hydrochloride has been prescribed to improve bladder control in cases of incontinence and excessive urination frequency. This review summarizes synthetic methods enabling the preparation of the racemic drug and, in a detailed...

  • Review
  • Open Access
3 Citations
4,510 Views
38 Pages

Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activity of the Irvingia Species

  • Branly-Natalien Nguena-Dongue,
  • Boniface Pone Kamdem,
  • Paul Keilah Lunga and
  • Fabrice Fekam Boyom

17 October 2023

Plants belonging to the genus Irvingia are widespread across the African and Southeast Asian regions of the world. Irvingia gabonensis, Irvingia malayana, and Irvingia grandifolia are among the commonly used species in ethnomedicine, especially in Af...

  • Article
  • Open Access
1 Citations
2,078 Views
17 Pages

15 October 2023

Treatment of hyperpigmented skin disorders by novel drug candidates without side effects remains an ongoing area of research. Chemically modified tetracyclines (CMTs) are a group of nonantimicrobial tetracycline drugs that have been shown to possess...

  • Article
  • Open Access
2,509 Views
14 Pages

Identification of Potential Non-Systemic Therapeutics for Hyperammonemia

  • Brad Nicklas,
  • Simon Velasquez Morales,
  • Jian Qian,
  • Kyle J. Stephens,
  • David R. Corbin,
  • Mark B. Shiflett,
  • Cory J. Berkland and
  • Alan M. Allgeier

30 September 2023

A non-absorbable therapeutic candidate for the treatment of hyperammonemia has been identified and characterized. Conventional approaches to reducing ammonia concentration in the blood and colon include acidifying the colon, inhibiting the bacterial...

  • Article
  • Open Access
2 Citations
2,605 Views
15 Pages

Bioactive Components of Myracrodruon urundeuva against SARS-CoV-2: A Computational Study

  • Sabrina Kelly Silva Alves,
  • Cássio Silva Sousa,
  • Edilanne Katrine Amparo Viana,
  • Hellen Cris Araújo Souza,
  • Maycon Douglas Araújo Souza,
  • Arthur Serejo Neves Ribeiro,
  • Vanessa de Sousa do Vale,
  • Muhammad Torequl Islam,
  • Joabe Lima Araújo and
  • Jefferson Almeida Rocha

27 September 2023

SARS-CoV-2 (severe acute respiratory distress syndrome coronavirus 2) is the causative agent for the novel coronavirus disease 2019 (COVID-19). It raises serious biosecurity questions due to its high contagious potential, thereby triggering rapid and...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Drugs Drug Candidates - ISSN 2813-2998